Investment Trends in European Digital Health

ByPiotr Wrzosinski

Where Capital Flows

Investors favor:

  • AI-powered platforms
  • Value-based care tools
  • Female health (menopause, hormones)

Valuation Benchmarks:

  • 4–6x revenue for most healthtech
  • 6–8x for AI/diagnostics
  • 10–14x EV/EBITDA for EBITDA-positive firms

Learn more at Scaling MedTech: From Product to Market

This post is part of SaMD Europe Launch Guide.

This content has been enhanced by GenAI tools.

Piotr Wrzosinski

Piotr Wrzosinski is a life sciences commercial and digital transformation leader with 20+ years of experience across pharma, medtech, and consulting. He writes about medtech, digital health, commercialization, AI, and regulation in Europe through an operator lens focused on adoption, evidence, and scale.